Abstract:The low efficiency of somatic cell nuclear transfer (SCNT) has been attributed mostly to inefficient epigenetic reprogramming. Recently, various histone deacetylase inhibitors (HDACi) were used to improve developmental competence of SCNT embryos in several species. However, limited information is available on the effects of quisinostat (JNJ-26481585, JNJ), a second-generation HDACi with high cellular potency towards Class I and II histone deacetylases. Based on our previous study, among various concentrations, treatment with 100 nM JNJ could improve embryo development into blastocysts compared with the control (23.50 ± 1.30 v. 13.97 ± 1.37; P < 0.05). Thus, in the present study, treatment with 100 nM JNJ was used for further investigation into the relative expression of genes related to pluripotency and reprogramming in order to assess the quality of pre-implantation embryos cultured in media with JNJ using quantitative real-time PCR. Porcine fibroblasts isolated from kidney of adult pigs from passage 6 to 8 were used as nuclear donor cells for SCNT. After SCNT, embryos were cultured with or without 100 nM JNJ during the first 24 h of in vitro culture, and blastocysts from each experimental group were collected and kept at –80°C until analysis. Total RNAs were extracted, and transcribed into cDNA before amplification. Then, the relative expression of development-related (Oct4, Sox2, and Nanog), histone acetylation-related (HDAC1, HDAC2, and HDAC3) and DNA methylation-related (DNMT1, DNMT3a, and DNMT3b) genes between the control and 100 nM JNJ groups were compared. All experiments were repeated 4 times and results were analysed by independent t-test using SPSS 17.0K (SPSS Inc., Chicago, IL, USA). Treatment with 100 nM JNJ showed significant increases in the expression Oct4, Sox2, and Nanog compared with the control (P < 0.05). Moreover, there was significantly lower expression of HDAC1, HDAC2, HDAC3, DNMT1, DNMT3a, and DNMT3b in the 100 nM JNJ treatment than in the control (P < 0.05). These expression results moderately illustrated more active transcriptional factors, stable maintenance of embryonic pluripotency, and lesser activity of histone acetylation and DNA methylation enzymes, enhancing the blastocyst formation rate in the treatment group. In conclusion, we suggest that improvement of the in vitro developmental competence of porcine SCNT embryos might be related to positive regulations of JNJ on the expression levels of genes related to pluripotency and reprogramming. This study was supported by the NRF (#2015R1C1A2A01054373; 2016M3A9B6903410), Research Institute for Veterinary Science and the BK21 PLUS Program.

27 Quisinostat, a Potent Histone Deacetylase Inhibitor, Regulates the Expression of Pluripotency- and Reprogramming-Related Genes on Somatic Cell Nuclear Transferred Porcine Embryos

Improved Early Development of Porcine Cloned Embryos by Treatment with Quisinostat, a Potent Histone Deacetylase Inhibitor

Quisinostat Treatment Improves Histone Acetylation and Developmental Competence of Porcine Somatic Cell Nuclear Transfer Embryos

139 TRICHOSTATIN A IMPROVED IN VITRO DEVELOPMENT OF PORCINE NUCLEAR TRANSFER EMBRYOS PRODUCED BY A NEW ACTIVATION METHOD

Effect of Histone Acetylation Modification with MGCD0103, a Histone Deacetylase Inhibitor, on Nuclear Reprogramming and the Developmental Competence of Porcine Somatic Cell Nuclear Transfer Embryos

Pxd101 Significantly Improves Nuclear Reprogramming and the in Vitro Developmental Competence of Porcine Scnt Embryos

The Histone Deacetylase Inhibitor, CI994, Improves Nuclear Reprogramming and in Vitro Developmental Potential of Cloned Pig Embryos.

The Cyclin-Dependent Kinase Inhibitor, JNJ-7706621, Improves in Vitro Developmental Competence of Porcine Parthenogenetic Activation and Somatic Cell Nuclear Transfer Embryos.

The HDAC Inhibitor LAQ824 Enhances Epigenetic Reprogramming and in Vitro Development of Porcine SCNT Embryos

Cotreatment with RepSox and LBH589 Improves the in Vitro Developmental Competence of Porcine Somatic Cell Nuclear Transfer Embryos.

Significant improvement of pig cloning efficiency by treatment with LBH589 after somatic cell nuclear transfer.

Enhancement of Epigenetic Reprogramming Status of Porcine Cloned Embryos with Zebularine, a DNA Methyltransferase Inhibitor

Effects of DNMT1 and HDAC Inhibitors on Gene-Specific Methylation Reprogramming During Porcine Somatic Cell Nuclear Transfer.

Down-Regulation of H3K4me3 by MM-102 Facilitates Epigenetic Reprogramming of Porcine Somatic Cell Nuclear Transfer Embryos

BIX-01294 Increases Pig Cloning Efficiency by Improving Epigenetic Reprogramming of Somatic Cell Nuclei.

DOT1L Inhibitor Improves Early Development of Porcine Somatic Cell Nuclear Transfer Embryos.

Effects of Histone Deacetylase Inhibitor Oxamflatin on in Vitro Porcine Somatic Cell Nuclear Transfer Embryos.

CUDC-101, a Histone Deacetylase Inhibitor, Improves the in Vitro and in Vivo Developmental Competence of Somatic Cell Nuclear Transfer Pig Embryos.

Scriptaid Affects Histone Acetylation and the Expression of Development-Related Genes at Different Stages of Porcine Somatic Cell Nuclear Transfer Embryo During Early Development

Oxamflatin Significantly Improves Nuclear Reprogramming, Blastocyst Quality, and in Vitro Development of Bovine SCNT Embryos.

Dynamic Methylation Changes of DNA and H3K4 by RG108 Improve Epigenetic Reprogramming of Somatic Cell Nuclear Transfer Embryos in Pigs